Yüklüyor......
Current Status of Autologous Stem Cell Transplantation in Relapsed and Refractory Hodgkin's Lymphoma
Despite the relatively high long-term disease-free survival (DFS) rate for patients with Hodgkin lymphoma (HL) with modern combination chemotherapy or combined modality regimens, ∼20% of patients die from progressive or relapsed disease. The standard treatment for relapsed and primary refractory HL...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
AlphaMed Press
2012
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3267827/ https://ncbi.nlm.nih.gov/pubmed/22210089 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2011-0177 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|